Endogenous Gdf15 activation limits adiposity and increases fecal energy excretion in mice
This study demonstrates that sustained elevation of endogenous GDF15 in mice prevents and reduces obesity by limiting fat accumulation and increasing fecal energy excretion through gut microbiota remodeling and altered ileal transcription, rather than by significantly suppressing food intake or increasing energy expenditure.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Obesity is often framed as a battle of willpower, a simple equation where eating more than you burn leads to weight gain. For decades, the scientific focus has been on the brain's appetite centers, trying to find a way to tell the body to stop wanting food. A promising player in this arena is a protein called GDF15. Produced naturally by cells throughout the body, this protein acts as a distress signal, rising in levels when the body faces stress, illness, or even intense exercise. In the past, scientists found that injecting massive, unnatural doses of this protein into mice could make them lose weight by suppressing their appetite. However, these high doses came with a catch: they often made the animals feel sick and unmotivated to move, mimicking the side effects of severe illness rather than a healthy metabolic shift. The big question remained: could a more moderate, natural increase in this protein, one that stays within the range the body can actually produce, help control weight without making the animal feel miserable?
A team of researchers set out to answer this by using a precise genetic tool to turn up the body's own production of GDF15, rather than injecting it from the outside. They focused on skeletal muscle, a large and metabolically active tissue, and used a method called CRISPR activation to gently boost the instructions for making the protein. They did not change the mouse's DNA sequence; they simply made the existing genes work a bit harder. The result was a steady, sustained rise in GDF15 levels in the bloodstream, reaching a high but natural range. When these mice were fed a diet designed to make them fat, they did not gain weight. Instead, they stayed lean, preserving their muscle mass while blocking the accumulation of body fat. This protection happened even though the mice did not eat significantly less food than the control group, and their energy expenditure—the calories they burned just by existing and moving—remained exactly the same.
The researchers then investigated how this was possible. They discovered that the weight protection relied entirely on a specific receptor in the brain called GFRAL, which acts as the docking station for GDF15. When they tested mice that lacked this receptor, the protein boost no longer worked, and the animals gained weight just like the controls. This confirmed that the effect was not a side effect of the genetic tool itself but a direct result of the protein signaling through its natural pathway. Surprisingly, the mice with elevated GDF15 did not lose their desire to run on exercise wheels, a common side effect seen with high-dose drug treatments. This suggested that a gentle, sustained increase in the protein could separate the benefits of weight control from the sickness and lethargy usually associated with it.
The most unexpected discovery came when the scientists looked at what happened to the energy the mice consumed. Since the animals were not eating less and not burning more, the missing calories had to be going somewhere else. The researchers found that the mice were excreting significantly more energy in their feces. The waste produced was not only heavier but also richer in energy, meaning the body was failing to extract as many calories from the food as it normally would. This increase in fecal energy loss accounted for the difference in weight gain. To understand why this was happening, the team examined the mice's gut. They found that the elevated GDF15 had reshaped the community of bacteria living in the intestine and altered the genetic activity of the gut lining itself. The gut wall appeared to shift from a state of efficient nutrient absorption to a state focused on defense and remodeling, effectively letting more calories pass through the body unabsorbed.
This effect was not limited to preventing weight gain. When the researchers applied the same treatment to mice that were already obese, the animals began to lose weight, again without eating less. The treatment reduced their body fat while keeping their muscle mass intact, and it once again led to an increase in the energy lost through feces. The study suggests that GDF15 does more than just tell the brain to stop eating; it also changes how the gut handles food, creating a new pathway for weight control that operates independently of appetite. While the research was conducted in mice, it points to a previously overlooked mechanism where the body can regulate its energy balance by simply letting more energy pass through without being absorbed, offering a new perspective on how metabolic signals might be harnessed to treat obesity.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.